2026 Q1 -tulosraportti
46 päivää sitten
‧28 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 200 | SWB | NON | ||
| 18 410 | AVA | AVA | ||
| 16 000 | AVA | AVA | ||
| 5 590 | NON | AVA | ||
| 3 048 | AVA | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 19.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 28.4. | ||
2025 Q4 -tulosraportti 20.2. | ||
2025 Q3 -tulosraportti 14.11.2025 | ||
2025 Q2 -tulosraportti 19.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
·2.6.The CEO is completely disconnected from the world: "Sales in the Nordics started in autumn 2024 and the company has so far received four orders in the Nordic market. – We have gone from being a development company to a commercial pharmaceutical company with sales in the Nordics, which is a very important milestone" He doesn't mention that the agreement states that the partner is obliged to purchase. The interesting thing is real sales. Here it's heading towards a share issue. In the middle of allergy season, and no orders are rolling in.
·5.6.For a long time, I have wondered aloud why JJ is still CEO at AC, and why he hasn't been fired. It is clear that his CV does not match his abilities. Therefore, there must be at least one board member protecting him. I have looked at the board members to see if there is a common thread. I can see that the chairman attended the same educational institution as JJ. So maybe it is the chairman who proposed JJ, and if she also has to fire him, it shows that she has poor judgment. That's why he won't be fired; they'd rather let the company go under. (I take the liberty of excluding that he has an intimate relationship with some of the board members.) I own shares in AcuCort, in a different account than the public one.
·2.6. · MuokattuNow, a PM should preferably come soon, that smells of increasing revenue and positive cash flow going forward - it's lagging a bit. Good agreements - but it looks like the market would like to see that there is actually some sales in the agreements.! 205,000 units at GAK 0.70 - would like to see it at price 5 within the next 18-24 months please.·3.6.Good 👌 The fact is that the product is not selling. This will not have high priority at Glenmark. At the same time, the application to sell the product will, at the earliest, be submitted late this year, early next year. With luck, approval will come towards the end of 2027. Then the product will be launched, and the allergy season 2028 will be lost without significant sales. The CEO constantly bluffs. Promises deals, speaks with big words. He has zero credibility. Not a man worth putting money on
·21.5.Suddenly it's happening.. What I'm waiting for.. I really delved into the company a long time ago.. I actually thought it would be over 1 riksdaler a long time ago but I'm staying even though I can sell at a profit right now . I believe and hope for some tasty pm.. maybe it will come maybe not we'll see....- ·30.4. · MuokattuZero revenue in Q4-25 and zero revenue in Q1-26. The CEO is very satisfied, and believes they are well on track, 1.5 years after market launch 🥴 There is zero interest in the product, unfortunately It is quickly heading towards a new share issue.
·7.5.Disappointing that they haven't been able to get sales going after such a long time and especially after the latest and very successful emission. They owe the shareholders to deliver a bit better. We weren't promised huge sales in the Nordics, but it has been far below expected. The most positive thing I have to say is that it's a good move to send letters to the shareholders. It's rare to get that nowadays, which also has something to do with people buying and selling shares very quickly. But I won't forget that. (Definitely not an angry shareholder either, but I'm out currently. Can't see any reason to re-enter right now).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
46 päivää sitten
‧28 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·2.6.The CEO is completely disconnected from the world: "Sales in the Nordics started in autumn 2024 and the company has so far received four orders in the Nordic market. – We have gone from being a development company to a commercial pharmaceutical company with sales in the Nordics, which is a very important milestone" He doesn't mention that the agreement states that the partner is obliged to purchase. The interesting thing is real sales. Here it's heading towards a share issue. In the middle of allergy season, and no orders are rolling in.·5.6.For a long time, I have wondered aloud why JJ is still CEO at AC, and why he hasn't been fired. It is clear that his CV does not match his abilities. Therefore, there must be at least one board member protecting him. I have looked at the board members to see if there is a common thread. I can see that the chairman attended the same educational institution as JJ. So maybe it is the chairman who proposed JJ, and if she also has to fire him, it shows that she has poor judgment. That's why he won't be fired; they'd rather let the company go under. (I take the liberty of excluding that he has an intimate relationship with some of the board members.) I own shares in AcuCort, in a different account than the public one.
- ·2.6. · MuokattuNow, a PM should preferably come soon, that smells of increasing revenue and positive cash flow going forward - it's lagging a bit. Good agreements - but it looks like the market would like to see that there is actually some sales in the agreements.! 205,000 units at GAK 0.70 - would like to see it at price 5 within the next 18-24 months please.·3.6.Good 👌 The fact is that the product is not selling. This will not have high priority at Glenmark. At the same time, the application to sell the product will, at the earliest, be submitted late this year, early next year. With luck, approval will come towards the end of 2027. Then the product will be launched, and the allergy season 2028 will be lost without significant sales. The CEO constantly bluffs. Promises deals, speaks with big words. He has zero credibility. Not a man worth putting money on
- ·21.5.Suddenly it's happening.. What I'm waiting for.. I really delved into the company a long time ago.. I actually thought it would be over 1 riksdaler a long time ago but I'm staying even though I can sell at a profit right now . I believe and hope for some tasty pm.. maybe it will come maybe not we'll see....
- ·30.4. · MuokattuZero revenue in Q4-25 and zero revenue in Q1-26. The CEO is very satisfied, and believes they are well on track, 1.5 years after market launch 🥴 There is zero interest in the product, unfortunately It is quickly heading towards a new share issue.·7.5.Disappointing that they haven't been able to get sales going after such a long time and especially after the latest and very successful emission. They owe the shareholders to deliver a bit better. We weren't promised huge sales in the Nordics, but it has been far below expected. The most positive thing I have to say is that it's a good move to send letters to the shareholders. It's rare to get that nowadays, which also has something to do with people buying and selling shares very quickly. But I won't forget that. (Definitely not an angry shareholder either, but I'm out currently. Can't see any reason to re-enter right now).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 200 | SWB | NON | ||
| 18 410 | AVA | AVA | ||
| 16 000 | AVA | AVA | ||
| 5 590 | NON | AVA | ||
| 3 048 | AVA | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 19.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 28.4. | ||
2025 Q4 -tulosraportti 20.2. | ||
2025 Q3 -tulosraportti 14.11.2025 | ||
2025 Q2 -tulosraportti 19.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
46 päivää sitten
‧28 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 19.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 28.4. | ||
2025 Q4 -tulosraportti 20.2. | ||
2025 Q3 -tulosraportti 14.11.2025 | ||
2025 Q2 -tulosraportti 19.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·2.6.The CEO is completely disconnected from the world: "Sales in the Nordics started in autumn 2024 and the company has so far received four orders in the Nordic market. – We have gone from being a development company to a commercial pharmaceutical company with sales in the Nordics, which is a very important milestone" He doesn't mention that the agreement states that the partner is obliged to purchase. The interesting thing is real sales. Here it's heading towards a share issue. In the middle of allergy season, and no orders are rolling in.·5.6.For a long time, I have wondered aloud why JJ is still CEO at AC, and why he hasn't been fired. It is clear that his CV does not match his abilities. Therefore, there must be at least one board member protecting him. I have looked at the board members to see if there is a common thread. I can see that the chairman attended the same educational institution as JJ. So maybe it is the chairman who proposed JJ, and if she also has to fire him, it shows that she has poor judgment. That's why he won't be fired; they'd rather let the company go under. (I take the liberty of excluding that he has an intimate relationship with some of the board members.) I own shares in AcuCort, in a different account than the public one.
- ·2.6. · MuokattuNow, a PM should preferably come soon, that smells of increasing revenue and positive cash flow going forward - it's lagging a bit. Good agreements - but it looks like the market would like to see that there is actually some sales in the agreements.! 205,000 units at GAK 0.70 - would like to see it at price 5 within the next 18-24 months please.·3.6.Good 👌 The fact is that the product is not selling. This will not have high priority at Glenmark. At the same time, the application to sell the product will, at the earliest, be submitted late this year, early next year. With luck, approval will come towards the end of 2027. Then the product will be launched, and the allergy season 2028 will be lost without significant sales. The CEO constantly bluffs. Promises deals, speaks with big words. He has zero credibility. Not a man worth putting money on
- ·21.5.Suddenly it's happening.. What I'm waiting for.. I really delved into the company a long time ago.. I actually thought it would be over 1 riksdaler a long time ago but I'm staying even though I can sell at a profit right now . I believe and hope for some tasty pm.. maybe it will come maybe not we'll see....
- ·30.4. · MuokattuZero revenue in Q4-25 and zero revenue in Q1-26. The CEO is very satisfied, and believes they are well on track, 1.5 years after market launch 🥴 There is zero interest in the product, unfortunately It is quickly heading towards a new share issue.·7.5.Disappointing that they haven't been able to get sales going after such a long time and especially after the latest and very successful emission. They owe the shareholders to deliver a bit better. We weren't promised huge sales in the Nordics, but it has been far below expected. The most positive thing I have to say is that it's a good move to send letters to the shareholders. It's rare to get that nowadays, which also has something to do with people buying and selling shares very quickly. But I won't forget that. (Definitely not an angry shareholder either, but I'm out currently. Can't see any reason to re-enter right now).
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 200 | SWB | NON | ||
| 18 410 | AVA | AVA | ||
| 16 000 | AVA | AVA | ||
| 5 590 | NON | AVA | ||
| 3 048 | AVA | NON |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt